Evidence map›Paper›PMID 42450264›Full record

ArticleInternational journal of molecular sciences2026

Combining Diclofenac and Cannabidiol to Enhance the Antibacterial Capacity of Nonantibiotic Drugs Through Potentiation.

Gratiela Gradisteanu Pircalabioru, Bianca Maria Tihauan, Ciprian Iliescu, Florina Silvia Iliescu

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Gratiela Gradisteanu PircalabiorueBio-Hub Centre of Excellence in Bioengineering, National University of Science and Technology POLITEHNICA Bucharest, 060042 Bucharest, Romania.ORCID 0000-0002-6384-1822
Bianca Maria TihauaneBio-Hub Centre of Excellence in Bioengineering, National University of Science and Technology POLITEHNICA Bucharest, 060042 Bucharest, Romania.
Ciprian IliescueBio-Hub Centre of Excellence in Bioengineering, National University of Science and Technology POLITEHNICA Bucharest, 060042 Bucharest, Romania.ORCID 0000-0001-7042-5248
Florina Silvia IliescueBio-Hub Centre of Excellence in Bioengineering, National University of Science and Technology POLITEHNICA Bucharest, 060042 Bucharest, Romania.ORCID 0000-0001-8808-8876

Funding

HORIZON-WIDERA-2022-TALENTS-01 101087007
6 · The paper itself

Abstract

Antimicrobial resistance demands intensive research on new nonantibiotics and drug repurposing to expand the arsenal of antimicrobial agents. The present work analysed the combination of diclofenac (DFNAC) and cannabidiol (CBD) and evaluated its potentiation and its biocompatibility. The formulation's potency has been tested against

Indexed as

Anti-Bacterial AgentsCannabidiolDiclofenacDrug SynergismEscherichia coliHumansMicrobial Sensitivity TestsPseudomonas aeruginosaStaphylococcus aureusStaphylococcus epidermidisAnti-Bacterial AgentsCannabidiolDiclofenacantimicrobialcannabidioldiclofenacpersonalised medicinepotentiationsynergism

Identifiers

PMID42450264
PMCPMC13361921

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.